Primary |
Psychotic Disorder |
14.1% |
Depression |
10.9% |
Schizophrenia |
9.4% |
Schizophrenia, Paranoid Type |
9.4% |
Product Used For Unknown Indication |
7.8% |
Schizoaffective Disorder Depressive Type |
7.8% |
Anxiety |
6.3% |
Injury |
6.3% |
Obstruction |
6.3% |
Schizoaffective Disorder |
4.7% |
Metabolic Disorder |
3.1% |
Pain |
3.1% |
Drug Therapy |
1.6% |
Epilepsy |
1.6% |
Ex-tobacco User |
1.6% |
Hypertension |
1.6% |
Neurosis |
1.6% |
Panic Attack |
1.6% |
Post Concussion Syndrome |
1.6% |
|
Speech Disorder Developmental |
8.3% |
Supraventricular Tachycardia |
8.3% |
Tardive Dyskinesia |
8.3% |
Weight Increased |
8.3% |
Asthenia |
4.2% |
Cognitive Disorder |
4.2% |
Confusional State |
4.2% |
Drug Ineffective |
4.2% |
Epilepsy |
4.2% |
Foetal Exposure During Pregnancy |
4.2% |
Insomnia |
4.2% |
Muscular Weakness |
4.2% |
Nervous System Disorder |
4.2% |
Neuroleptic Malignant Syndrome |
4.2% |
Neurological Examination Abnormal |
4.2% |
Oesophageal Atresia |
4.2% |
Rotator Cuff Syndrome |
4.2% |
Suicidal Ideation |
4.2% |
Suicide Attempt |
4.2% |
Transient Ischaemic Attack |
4.2% |
|
Secondary |
Schizophrenia |
18.1% |
Schizophrenia, Paranoid Type |
17.5% |
Product Used For Unknown Indication |
11.8% |
Depression |
10.6% |
Anxiety |
7.6% |
Psychotic Disorder |
7.3% |
Drug Use For Unknown Indication |
6.0% |
Epilepsy |
3.3% |
Injury |
2.4% |
Obstruction |
2.4% |
Foetal Exposure During Pregnancy |
2.1% |
Bipolar Disorder |
1.8% |
Hallucination |
1.8% |
Mental Disorder |
1.5% |
Pain |
1.2% |
Adverse Event |
0.9% |
Asperger's Disorder |
0.9% |
Blood Cholesterol |
0.9% |
Dementia |
0.9% |
Laxative Supportive Care |
0.9% |
|
Weight Increased |
30.0% |
Blood Cholesterol Increased |
6.0% |
Extrapyramidal Disorder |
6.0% |
Latent Autoimmune Diabetes In Adults |
6.0% |
Tension |
6.0% |
Vitamin K Deficiency |
6.0% |
Maternal Drugs Affecting Foetus |
4.0% |
Neuroleptic Malignant Syndrome |
4.0% |
Psychotic Disorder |
4.0% |
Retinopathy |
4.0% |
Vitreous Disorder |
4.0% |
Withdrawal Syndrome |
4.0% |
Alopecia |
2.0% |
Asthenia |
2.0% |
Chronic Obstructive Pulmonary Disease |
2.0% |
Drug Abuse |
2.0% |
Drug Hypersensitivity |
2.0% |
Drug Ineffective |
2.0% |
Drug Withdrawal Syndrome Neonatal |
2.0% |
Foetal Exposure During Pregnancy |
2.0% |
|
Concomitant |
Depression |
18.4% |
Schizophrenia |
17.4% |
Bipolar Disorder |
16.4% |
Anxiety |
7.7% |
Sleep Disorder |
5.7% |
Major Depression |
4.0% |
Psychotic Disorder |
4.0% |
Schizoaffective Disorder |
3.4% |
Insomnia |
3.1% |
Pain |
3.0% |
Hypertension |
2.2% |
Mental Disorder |
2.0% |
Schizophrenia, Paranoid Type |
1.9% |
Agitation |
1.9% |
Product Used For Unknown Indication |
1.7% |
Diabetes Mellitus |
1.5% |
Drug Use For Unknown Indication |
1.4% |
Hallucination, Auditory |
1.4% |
Hyperlipidaemia |
1.4% |
Affective Disorder |
1.3% |
|
Type 2 Diabetes Mellitus |
33.7% |
Weight Increased |
13.0% |
Pancreatitis |
9.7% |
Tardive Dyskinesia |
9.4% |
Diabetes Mellitus |
5.8% |
Tearfulness |
3.3% |
Type 1 Diabetes Mellitus |
3.3% |
Death |
2.2% |
Vomiting |
2.2% |
Wheelchair User |
2.2% |
Diabetic Ketoacidosis |
1.7% |
Obesity |
1.7% |
Sedation |
1.7% |
Urinary Tract Infection |
1.7% |
Uterine Leiomyoma |
1.7% |
Vision Blurred |
1.7% |
Diabetic Coma |
1.4% |
Suicide Attempt |
1.4% |
Vulvovaginal Candidiasis |
1.4% |
Diabetic Neuropathy |
1.1% |
|
Interacting |
Hallucination |
25.0% |
Dementia |
12.5% |
Depression |
12.5% |
Hepatitis C |
12.5% |
Hiv Infection |
12.5% |
Schizoaffective Disorder |
12.5% |
Extrapyramidal Disorder |
6.3% |
Schizophrenia |
6.3% |
|
Extrapyramidal Disorder |
40.0% |
Priapism |
20.0% |
Pyrexia |
20.0% |
Toxicity To Various Agents |
20.0% |
|